22 results on '"Motoya, Satoshi"'
Search Results
2. Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study
3. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey
4. Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
5. A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan
6. Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial
7. Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses
8. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
9. Evidence-based clinical practice guidelines for inflammatory bowel disease
10. Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
11. Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
12. An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease
13. Genetic characteristics of inflammatory bowel disease in a Japanese population
14. First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis
15. Disease susceptibility genes shared by primary biliary cirrhosis and Crohn’s disease in the Japanese population
16. Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
17. Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective study
18. C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease
19. Sargramostim in patients with Crohn’s disease: results of a phase 1–2 study
20. Adsorptive granulocyte and monocyte apheresis for refractory Crohn?s disease: an open multicenter prospective study
21. Rapidly growing early gastric cancer with microsatellite instability
22. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.